Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Faslodex Specific Clinical Experience Investigation for Long-term Use

NCT01501266 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01501266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01501266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Faslodex Specific Clinical Experience Investigation for Long-term Use
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
January 31, 2015
Enrollment
660 (estimated)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer